News
Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...
Eli Lilly will raise UK list prices for its Mounjaro weight-loss jab by as much as 170% from September after Donald Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback